methotrexate has been researched along with Arteriosclerosis, Coronary in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, M; Lai, JM; Li, SN; Wang, XL; Yue, T | 1 |
| Anderson, DR; Baker, JF; England, BR; George, MD; Johnson, TM; Liao, KP; Mikuls, TR; Roul, P; Sauer, B; Sayles, HR; Zheng, C | 1 |
| Barbieri, LR; Carvalho, PO; Gutierrez, PS; Lourenço-Filho, DD; Maranhão, RC; Stolf, NAG; Tavares, ER | 1 |
| Bertrand, O; Butman, S; Clearfield, M; Everett, BM; Glynn, RJ; Goldhaber, SZ; Gupta, M; Hasan, A; Iturriaga, E; Johnston, J; Le May, M; Libby, P; MacFadyen, JG; Mam, V; Ofori, C; Paynter, NP; Pradhan, A; Ridker, PM; Rosenberg, Y; Saklayen, M; Seagle, R; Singh, N; Solomon, DH; Tsigoulis, M; Verma, S; Zaharris, E | 1 |
| Antohe, JL; Bili, A; Bozaite, R; Kirchner, HL; Morris, SJ; Pranesh, S; Tang, X; Wasko, MC | 1 |
| Andrews, J; Baxter, P; Buch, MH; Erhayiem, B; Greenwood, JP; Pavitt, S; Plein, S | 1 |
| Blegvad, J; Ellingsen, T; Hedemann-Nielsen, A; Herly, M; Kristensen, LD; Laurbjerg, TB; Løgstrup, BB; Masic, D; Urbonaviciene, G | 1 |
| Arbab-Zadeh, A; Kiani, AN; Lima, J; Magder, LS; Petri, M; Vogel-Claussen, J | 1 |
| Kappert, U; Mahlmann, A; Ouda, A; Pfluecke, C; Simonis, G; Weiss, N | 1 |
2 trial(s) available for methotrexate and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Topics: Aged; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; Confidence Intervals; Coronary Artery Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Interleukin-1beta; Interleukin-6; Male; Metabolic Syndrome; Methotrexate; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Statistics, Nonparametric; Stroke; Transaminases | 2019 |
Coronary Artery Disease Evaluation in Rheumatoid Arthritis (CADERA): study protocol for a randomized controlled trial.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Protocols; Contrast Media; Coronary Artery Disease; Drug Therapy, Combination; England; Etanercept; Humans; Immunoglobulin G; Magnetic Resonance Imaging, Cine; Methotrexate; Predictive Value of Tests; Prevalence; Prospective Studies; Receptors, Tumor Necrosis Factor; Research Design; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
7 other study(ies) available for methotrexate and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
[Clinical analysis of 5 cases of systemic juvenile idiopathic arthritis with coronary artery dilatation].
Topics: Arthritis, Juvenile; Biological Factors; Child; Coronary Aneurysm; Coronary Artery Disease; Dilatation; Dilatation, Pathologic; Female; Humans; Infant; Male; Methotrexate; Prednisone; Retrospective Studies | 2022 |
Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Coronary Artery Disease; Female; Heart Disease Risk Factors; Heart Failure; Hospitalization; Humans; Incidence; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Stroke | 2021 |
Influence of Drugs Carried in Lipid Nanoparticles in Coronary Disease of Rabbit Transplanted Heart.
Topics: Animals; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Cytokines; Disease Models, Animal; Drug Carriers; Gene Expression Regulation; Graft Rejection; Graft Survival; Heart Transplantation; Immunohistochemistry; Immunosuppressive Agents; Injections, Intravenous; Methotrexate; Myocardium; Nanoparticles; Paclitaxel; Rabbits; Real-Time Polymerase Chain Reaction; RNA | 2017 |
Tumor necrosis factor α inhibitor use and decreased risk for incident coronary events in rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Coronary Artery Disease; Female; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Tumor Necrosis Factor-alpha | 2014 |
Left ventricular function at two-year follow-up in treatment-naive rheumatoid arthritis patients is associated with anti-cyclic citrullinated peptide antibody status: a cohort study.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Case-Control Studies; Cohort Studies; Coronary Artery Disease; Denmark; Disease Progression; Echocardiography; Female; Humans; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Tomography, X-Ray Computed; Vascular Calcification; Ventricular Dysfunction, Left; Ventricular Function, Left | 2017 |
Semiquantified noncalcified coronary plaque in systemic lupus erythematosus.
Topics: Adult; Aged; Angiography; Antibodies, Antinuclear; Antirheumatic Agents; Calcinosis; Calcium; Coronary Artery Disease; Coronary Vessels; DNA; Female; Humans; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Plaque, Atherosclerotic; Risk Factors; Tomography, X-Ray Computed | 2012 |
Combined immunosuppressive therapy including a TNF-alpha blocker induces remission in a difficult to treat patient with Takayasu arteriitis and coronary involvement.
Topics: Adult; Antibodies, Monoclonal; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Drug Therapy, Combination; Echocardiography, Stress; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Magnetic Resonance Angiography; Methotrexate; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Takayasu Arteritis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2012 |